The impact of combining Selective Internal Radiation Therapy (SIRT) with Sorafenib on overall survival in patients with advanced hepatocellular carcinoma: The Soramic trial palliative cohort

被引：35

作者：

Ricke, J. ^{[1
]}

Sangro, B. ^{[2
]}

Amthauer, H. ^{[3
]}

Bargellini, I. ^{[4
]}

Bartenstein, P. ^{[5
]}

De Toni, E. ^{[6
]}

Gasbarrini, A. ^{[7
]}

Klumpen, H. -J. ^{[8
]}

Peck-Radosavljevic, M. ^{[9
]}

Popovic, P. ^{[10
]}

Rosmorduc, O. ^{[11
]}

Schott, E. ^{[12
]}

Van Buskirk, M. ^{[13
]}

Malfertheiner, P. ^{[14
]}

机构：

[1] Maximilians Univ Munich, Dept Radiol, Munich, Germany

[2] Clin Univ Navarra, Liver Unit, Pamplona, Spain

[3] Charite, Dept Nucl Med, Berlin, Germany

[4] Univ Pisa, Dept Diagnost & Intervent Radiol, Pisa, Italy

[5] Ludwig Maximilians Univ Munchen, Dept Nucl Med, Munich, Germany

[6] Ludwig Maximilians Univ Munchen, Dept Gastroenterol, Munich, Germany

[7] Univ Cattolica Sacro Cuore, Dept Gastroenterol, Rome, Italy

[8] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands

[9] Klinikum Klagenfurt, Dept Gastroenterol Austria, Klagenfurt, Austria

[10] Univ Ljubljana, Med Ctr, Dept Radiol, Ljubljana, Slovenia

[11] Univ Hosp St Antoine, Dept Hepatogastroenterol, Paris, France

[12] Charite, Dept Gastroenterol, Berlin, Germany

[13] Data Reduct LLC, Chester, PA USA

[14] Univ Hosp Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany

来源：

JOURNAL OF HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

10.1016/S0168-8278(18)30424-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LBO-005

引用

页码：S102 / S102

页数：1

共 50 条

[1] The impact of combining Selective Internal Radiation Therapy (SIRT) with sorafenib on overall survival in patients with advanced hepatocellular carcinoma: The SORAMIC trial palliative cohort
Ricke, J.
Sangro, B.
Amthauer, H.
Bargellini, I.
Bartenstein, P.
De Toni, E.
Gasbarrini, A.
Klumpen, H. J.
Peck, M.
Popovic, P.
Rosmorduc, O.
Schott, E.
Verslype, C.
Malfertheiner, P.
ANNALS OF ONCOLOGY, 2018, 29
[2] Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Ricke, Jens
Klumpen, Heinz Josef
Amthauer, Holger
Bargellini, Irene
Bartenstein, Peter
de Toni, Enrico N.
Gasbarrini, Antonio
Pech, Maciej
Peck-Radosavljevic, Markus
Popovic, Peter
Rosmorduc, Olivier
Schott, Eckart
Seidensticker, Max
Verslype, Chris
Sangro, Bruno
Malfertheiner, Peter
JOURNAL OF HEPATOLOGY, 2019, 71 (06) : 1164 - 1174
[3] Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial
Surov, Alexey
Wienke, Andreas
Borggrefe, Jan
Hinnerichs, Mattes
Seidensticker, Ricarda
Oecal, Osman
Schuette, Kerstin
Zech, Christoph J.
Loewe, Christian
van Delden, Otto
Vandecaveye, Vincent
Verslype, Chris
Gebauer, Bernhard
Sengel, Christian
Bargellini, Irene
Iezzi, Roberto
Malfertheiner, Peter
Berg, Thomas
Kluempen, Heinz J.
Benckert, Julia
Gasbarrini, Antonio
Amthauer, Holger
Sangro, Bruno
Ricke, Jens
Seidensticker, Max
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (08) : 1016 - 1027
[4] Overall survival of patients with hepatocellular carcinoma receiving sorafenib versus selective internal radiation therapy with predicted osimetry in the SARAH trial
Hawkins, N. S.
Ross, P. J.
Palmer, D. H.
Chatellier, G.
Pereira, H.
Vilgrain, V.
ANNALS OF ONCOLOGY, 2019, 30
[5] Survival and Response after Selective Internal Radiation Therapy (SIRT) for advanced Hepatocellular Carcinoma
Hamami, M. E.
Mueller, S.
Boy, C.
Poeppel, T. D.
Ertle, J.
Hilgard, P.
Antoch, G.
Bockisch, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S201 - S201
[6] Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial
Schuette, Kerstin
Schinner, Regina
Fabritius, Mathias P.
Moeller, Melina
Kuhl, Christiane
Iezzi, Roberto
Ocal, Osman
Pech, Maciej
Peynircioglu, Bora
Seidensticker, Max
Sharma, Rohini
Palmer, Daniel
Bronowicki, Jean-Pierre
Reimer, Peter
Malfertheiner, Peter
Ricke, Jens
LIVER CANCER, 2020, 9 (06) : 771 - 786
[7] Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)
Finessi, Monica
Cioffi, Martina
Grimaldi, Serena
Fronda, Marco
Rovera, Guido
Passera, Roberto
Carucci, Patrizia
Gaia, Silvia
Rolle, Emanuela
Rizza, Giorgia
Colli, Fabio
Saracco, Giorgio Maria
Romagnoli, Renato
Calandri, Marco
Fonio, Paolo
Morbelli, Silvia Daniela
Breatta, Andrea Doriguzzi
RADIOLOGIA MEDICA, 2025, 130 (02): : 271 - 279
[8] ALBI score affects Overall Survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)
Cioffi, M.
Grimaldi, S.
Fronda, M.
Breatta, A. Doriguzzi
Rovera, G.
Passera, R.
Fonio, P.
Morbelli, S.
Finessi, M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S411 - S411
[9] The impact of post-progression survival on overall survival of patients with advanced hepatocellular carcinoma treated by sorafenib therapy
Terashima, Takeshi
Yamashita, Tatsuya
Takata, Noboru
Nakagawa, Hidetoshi
Arai, Kuniaki
Kagaya, Takashi
Mizukoshi, Eishiro
Honda, Masao
Kaneko, Shuichi
HEPATOLOGY, 2013, 58 : 1221A - 1221A
[10] The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial
Labeur, Tim A.
Hofsink, Quincy
Takkenberg, R. Bart
van Delden, Otto M.
Mathot, Ron A. A.
Schinner, Regina
Malfertheiner, Peter
Amthauer, Holger
Schuette, Kerstin
Basu, Bristi
Kuhl, Christiane
Mayerle, Julia
Ricke, Jens
Klumpen, Heinz-Josef
ACTA ONCOLOGICA, 2020, 59 (09) : 1028 - 1035

← 1 2 3 4 5 →